Neuroone Medical Technologies (NMTC) Shares Outstanding (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Shares Outstanding (Entity) came in at $8.6 million in Q1 2026, up 64.7% YoY from $5.2 million in Q1 2025, and up 2.54% on a QoQ basis from $8.4 million in Q4 2025.
Neuroone Medical Technologies (NMTC) Shares Outstanding (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 17 years of Shares Outstanding (Entity) data on file, last reported at $8.6 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 64.7% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 64.7% YoY) and the FY2025 annual result came in at $6.7 million, up 30.3% from the prior year.
- Shares Outstanding (Entity) climbed to $8.6 million in Q1 2026, from $8.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $8.6 million in Q1 2026 to a low of $2.7 million in Q1 2022.
- A 5-year average of $4.7 million and a median of $4.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) gained 0.31% — and 2025, when it surged 78.93%.
- Tracing NMTC's Shares Outstanding (Entity) over 5 years: stood at $2.7 million in 2022, then surged by 52.92% to $4.1 million in 2023, then grew by 24.21% to $5.1 million in 2024, then jumped by 63.46% to $8.4 million in 2025, then gained by 2.54% to $8.6 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $8.6 million (Q1 2026), $8.4 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Neuroone Medical Technologies | 17.95 Mn | 15.91 Mn | 1.18 Mn | 8.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.48 Mn |
| Mar 31, 2026 | 8.48 Mn |
| Dec 31, 2025 | 8.39 Mn |
| Sep 30, 2025 | 6.69 Mn |
| Jun 30, 2025 | 8.10 Mn |
| Mar 31, 2025 | 5.19 Mn |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 4.46 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 2.93 Mn |
| Mar 31, 2023 | 2.74 Mn |
| Dec 31, 2022 | 2.71 Mn |
| Sep 30, 2022 | 2.67 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | 2.57 Mn |
| Sep 30, 2021 | 1.78 Mn |